What has FDA cited under 21 CFR 211.100(a)?

1 DSRV article cite 21 CFR 211.100(a). Enforcement cases behind them: FDA Warning Letter CMS Case 732115 to ABS Corporation, July 23, 2026. Inspection exposure across them: 1 high.

What does DSRV recommend for 21 CFR 211.100(a)?

From the newest article (A Quality Unit That Averaged Away Its Own OOS Failures): The decisive control is whether the quality system forces failing data to be investigated before specifications, retest logic, or batch disposition can be changed. DSRV is decision support, not legal advice; verify against the official source each article names.

Browse by regulation1 article · 1 high

21 CFR 211.100(a)

Every DSRV article whose Regulatory Snapshot cites 21 CFR 211.100(a): the enforcement case behind it, the inspection exposure it created, and what the desk would do about it.

Inspection exposure across the set

What has FDA cited under 21 CFR 211.100(a)?: 1 DSRV article cite 21 CFR 211.100(a). Enforcement cases behind them: FDA Warning Letter CMS Case 732115 to ABS Corporation, July 23, 2026. Inspection exposure across them: 1 high.
What does DSRV recommend for 21 CFR 211.100(a)?: From the newest article (A Quality Unit That Averaged Away Its Own OOS Failures): The decisive control is whether the quality system forces failing data to be investigated before specifications, retest logic, or batch disposition can be changed. DSRV is decision support, not legal advice; verify against the official source each article names.

August 20264 min readHigh exposurecited as a tag
A Quality Unit That Averaged Away Its Own OOS Failures
FDA's July 2026 warning letter to ABS Corporation shows a Quality Unit that averaged out failing assay results, handwrote higher specification limits onto batch records during validation, and released product made with a raw material that had already failed retesting. The pattern is not sloppy paperwork. It is a Quality Unit deciding the answer before the test ran.
Case
FDA Warning Letter CMS Case 732115 to ABS Corporation, July 23, 2026.
DSRV take
The decisive control is whether the quality system forces failing data to be investigated before specifications, retest logic, or batch disposition can be changed.

Address this risk

Pressure-test your evidence before an inspector reads it

Bring the document that has to hold up under 21 CFR 211.100(a). DSRV maps the evidence, names the gaps, and routes judgment calls to human review. Controlled intake, no public file upload.

Apply for the Stability Pilot Ask The Vault about 21 CFR 211.100(a)

Regulatory intelligence and interpretation, not legal advice. Verify against the official FDA or ICH source each article names.